A stabilizer of the interaction between the Estrogen Receptor alpha (ERα), a driver in the majority of breast cancers, and 14‐3‐3ζ, a negative regulator of ERα, is developed as anti‐cancer strategy. The gene discussed is ESR1; the disease is breast cancer.